Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
In this trial, the investigators will assess the effect of metoprolol in patients with
hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will
evaluate the quality of life, exercise tolerance, echocardiographic parameters and laboratory
marker of heart failure and myocardial injury.